HCM
CYTR

Highbridge Capital Management’s CytRx Corp CYTR Stock Holding History

Highbridge Capital Management’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,879
Closed -$199K – 1922
2016
Q2 		$199K Buy
+14,879
New +$247K ﹤0.01% 1232
2014
Q2 		– Sell
-35,909
Closed -$752K – 1464
2014
Q1 		$752K Buy
+35,909
New +$1.27M 0.01% 613

Other funds holding CYTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Highbridge Capital Management's CYTR Position: Q3 2016 in Review

Highbridge Capital Management sold out of CytRx Corp (CYTR) in Q3 2016, closing a stake of 14,879 shares — an estimated $199K sold.

Highbridge Capital Management first reported a position in CYTR in Q1 2014 and held it in 2 quarters. The position peaked at $752K in Q1 2014. 72 funds tracked by Wall St. Rank hold CYTR as of Q3 2016.

  • Highbridge Capital Management reported no remaining CytRx Corp position as of Q3 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 14,879 CytRx Corp shares in Q3 2016, an estimated $199K.
  • Highbridge Capital Management first reported a position in CytRx Corp in Q1 2014 and held it in 2 quarters.
  • Highbridge Capital Management's CytRx Corp position peaked at $752K in Q1 2014.
  • 72 funds tracked by Wall St. Rank held CytRx Corp as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.